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ABSTRACT
Alpha Particle Transport in Voxelized Trabecular Bone Images
by
George Tabatadze
Dr. Phillip W. Patton, Associate Professor 
Department of Health Physics 
University of Nevada, Las Vegas
Alpha particles are of current interest in radionuclide therapy due to their short 
range and high rates of energy transfer to target tissues. Published values of alpha- 
particle absorbed fractions in skeletal tissues do not vary with particle energy, cellularity 
or skeletal site. To correct for this, absorbed fractions are calculated using Monte Carlo 
techniques in 3D voxelized images. In this study absorbed fraction values are acquired 
for deep marrow (TAM), shallow marrow (TAMs), and trabecular bone volume (TBV) 
targets for a broad energy spectrum of alpha particles originating in the TAM, TAMs, and 
TBV of 33 voxelized images. Additionally the impact of marrow cellularity on absorbed 
fraction is investigated, by varying the fat percentage from 0% to 100% for each bone 
site.
Calculated absorbed fractions show an energy dependence for all source-target 
combinations. Additionally, AF(TAM<—TAM) is greatly influenced by marrow 
cellularity. These dependencies on energy and cellularity illustrate the weaknesses in the 
current ICRP methodology.
Ill
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CHAPTER 1 
INTRODUCTION
Trabecular bone regions play a large role in both the skeletal and hematopoietic 
systems. Active bone marrow which is located inside the trabecular bone cavities is the 
main site of blood cell production. Additionally, the radiosensitive progenitor cells are 
located in the marrow; therefore, it is very important to be able to accurately calculate the 
dose to this region. Since, bone marrow is located in trabecular bone cavities; the dose to 
the marrow is directly effected by the radionuclide distribution in trabecular bone. 
Radionuclides that are localized in bone, especially charged-particle emitters, have the 
potential to cause damage to marrow tissues (Hall, 1978).
Alpha particles are a highly ionizing form of particle radiation with low 
penetration ability. They consist of two protons and two neutrons bound together. 
Charged particles, including a-particles, deposit energy in biological materials through 
ionizations and excitations. The events tend to be localized along the tracks of individual 
ionizing particles, in a pattern that is dependent upon the type of radiation involved. 
Alpha particles are directly ionizing, giving rise to individual ionizing events which occur 
so closely together that they tend to overlap (Hall, 1978).
Alpha Particle Physics
The double positive charge and low velocity (due to their large mass) cause alpha 
particles to lose their energy over a relatively short distance (High LET). Since,
1
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a-particles are easily stopped by the protective layers of skin, they are only considered as 
an internal hazard.
An important consideration in the development of effective strategies for 
radioimmunotherapy is the nature of the radiation emitted by the radionuclide. Alpha 
particles have high collisional stopping powers, which provide increased energy 
deposition in the tumor sites with a decrease o f energy absorption in non-targeted tissues 
due to their extremely short range. This is one o f the advantages of a-particles over 
P-particle emitters. Furthermore, a-particles have a higher biological effectiveness, which 
is nearly independent of oxygen concentration, dose rate, and cell cycle position 
(Zalutsky, 2004).
Alpha immunotherapy is a combination of a-emitting radionuclides carried by 
targeting agents, which then selectively attach to cancer cells and destroy them by 
delivering large amounts of radiation. Ideally, the treatment would deliver the maximum 
dose to the tumor cells with a minimal dose to healthy cells. Based on practical 
dosimetric principles, there are several advantages of using high LET radionuclides in 
radiotherapeutic applications. For example, the mean LET value for the P-particle- 
emitting yttrium-90 is 0.2 keV/pm whereas that of astatine-211 is 97 keV/pm. 
Furthermore, the mean range in tissue of the Y-90 P-particle and the At-211 a-particle is 
3960 pm and 70 pm, respectively; therefore, the cytotoxicity induced by a-particles is far 
more selective (McDevitt et al., 1998). However, the treatment procedure requires these 
radionuclides travel through the blood stream, depositing energy in both bone, as well as, 
active hemopoietic marrow cavities in route to the tumor site. Since the active marrow is 
often the dose limiting organ in radioimmunotherapy, accurate methods to calculate the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
dose to the red marrow and the associated surrounding tissues must be developed.
Alpha-particle therapy using Ac-225 and its daughter product Bi-213 is a new and 
promising treatment for many forms of cancer. Clinical trials for acute myeloid leukemia 
have been promising with about 25% of terminal patients going into remission. 
Researchers throughout the world are examining approaches for prostate cancer, bladder 
cancer, ovarian cancer, and melanoma. Furthermore, increased interest has been shown 
in the potential of a-emitters in the treatment of other forms of leukemia and 
micrometastases (Meikrantz et al., 2006). Table 1.1 lists possible a-particle emitters that 
may be used for radioimmunotherapy.
Table 1.1. List of possible a-particle emitters that can be used for radioimmunotherapy 
(McDevitt et al., 1998).
Radionuclide
Daughters (b) Half-life %(a) Alpha Energy
Bi-213 45.6 min 2 5.9 MeV
Po-213 4.2 ps 98 8.4 MeV
Bi-212 1.0 h 36 6.0 MeV
Po-212 298 ns 64 8.8 MeV
At-211 7.21 h 42 5.9 MeV
Po-211 516 ms 58 7.4 MeV
Ac-225 10 days 100 5.8 MeV
Fr-211 4.9 min 100 6.4 MeV
At-217 32.3 ms 100 7.1 MeV
Ra-223 11.4 days 100 5.7 MeV
Rn-219 4 s 100 6.8 MeV
Po-215 1.8 ms 100 7.4 MeV
Bi-211 2.1 min 16 6.3 MeV
84 6.6 MeV
(a) Percent of alpha-particles emitted per decay of parent radionuclide
(b) Only alpha-emitting daughters are shown______________________
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Bone Anatomy and Physiology
To achieve an accurate representation o f the radiation transport in the skeleton, 
one must first understand bone anatomy and physiology. Osseous (bony) tissue is a 
supporting cormective tissue that contains specialized cells and matrix mainly consisting 
of extracellular protein fibers. Bone has four major characteristics: (1) the matrix o f bone 
is very dense and contains deposits of calcium salts; (2) the matrix contains bone cells, or 
osteocytes, within pockets called lacunae (typically organized around blood vessels that 
branch through the bony matrix); (3) Canaliculi, narrow passageways through the matrix, 
extend between the lacunae and nearby blood vessels, forming a branching network for 
the exchange of nutrients, waste products, and gasses; and (4) except at joints, the outer 
surfaces o f bones are covered by a periosteum, which consists of outer fibrous and inner 
cellular layers. The inner cavities of bones are covered by a thin layer of connective 
tissue called the endosteum (Martini, 2006). Figure 1.1 shows these bone structures.
Bone contains four types of cells: osteocytes, osteoblasts, osteoprogenitor cells, 
and osteoclasts. Osteocytes are formed by the incorporation of osteoblasts into the bone 
matrix. Osteocytes remain in contact with each other and with cells on the bone surface 
via gap junction-coupled cell processes passing through the matrix via the canaliculi, 
which connect the cell body-containing lacunae with each other and with the outside 
tissues. Osteocytes may (1) stabilize bone mineral, (2) detect micro fractures, and (3) 
respond to the amount and distribution of strain within bone tissue that influence adaptive 
modeling and remodeling behavior through cell to cell interactions. Osteocytes play a key 
role in homestatic, morphogenetic, and restructuring processes that regulate the mineral 
content and architecture of bone mass (Martini, 2006).
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Figure 1.1. (a) A diagram of a cortical bone segment illustrating the microstructure of 
bone; (b) Diagram of trabeculae and adjoining bone microstructure (Tortora 1989).
Osteoblasts are bone-forming cells that synthesize and secrete non-mineralized 
bone matrix, participate in the calcification and resorption of bone, and regulate the flux 
o f ealcium and phosphate in and out of bone. Bone formation oecurs in two stages: 
matrix formation and mineralization (Martini, 2006). Osteoprogenitor eells are
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mesenchymal cells that differentiate into osteoblasts. Osteoprogenitor cells arise in the 
embryo where they participate in the development of the skeleton. Some o f these cells 
persist in the adult body where they contribute to the replacement o f osteoblasts in bone 
turnover and in fracture healing.
Osteoclasts are responsible for breaking down bone. In order to allow the bone to 
withstand mechanieal stresses, old bone mass is broken down by osteoclasts and new 
bone formed by osteoblasts. Disturbance of this continuous bone remodeling ean lead to 
bone disorders such as osteoporosis (Martini, 2006).
In young individuals osteoblasts are more active than osteoclasts; therefore, total 
bone mass increases in humans for the first twenty to thirty years of life. Production and 
resorption reach equilibrium after age 30, thus, keeping bone mass constant for several 
years and after that resorption occurs at faster rates than bone production, which causes a 
net loss of bone mass (Keaveny and Yeh, 2002).
The major functional unit o f mature compact bone is the osteon, or Haversian 
system. In an osteon, the osteocytes are arranged in concentric layers around a central 
(Haversian) canal. This canal contains one or more blood vessels that carry blood to and 
from the osteon. Other passageways, known as Volkmann canals, extend roughly 
perpendicular to the surface. Blood vessels in these canals supply blood to osteons deeper 
in the bone and to tissues o f the marrow cavities. The lamellae of each osteon form a 
series o f nested cylinders around the central canal (Martini, 2006).
In spongy (trabecular) bone, lamellae are not arranged in osteons. The matrix in 
spongy bone forms struts and plates called trabeculae. Marrow is found between the 
trabeculae of spongy bone and blood vessels within this tissue deliver nutrients to the
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trabeculae and remove wastes generated by the osteoeytes (Martini, 2006).
Trabecular bone is loeated where bones are not heavily stressed or where stresses 
arrive from many direetions. The trabeeulae are oriented along stress lines. In addition to 
being able to withstand stress applied from many directions, trabecular bone is much 
lighter then compact bone, thus reducing the weight o f the skeleton and thereby making it 
easier for muscles to move the bones. Finally, the framework of trabeculae supports and 
protects the eells of the bone marrow. Trabecular bone eontains red bone marrow 
responsible for blood cell formation (Martini, 2006).
The endosteum lines each marrow cavity. This layer, which is active during bone 
growth, repair, and remodeling, covers the trabeculae o f spongy bone and lines the inner 
surface o f the eentral canals. The endosteum eontains both osteoblasts and osteoelasts 
(Martini, 2006).
With aging, thinning of trabeculae and loss of trabeculae oeeurs along with other 
specific morphological changes (Snyder et al., 1993). Horizontal trabeculae are lost at a 
greater rate than vertical trabeculae within the vertebrae (Parfitt et al., 1983; Mosekilde, 
1989). Analyses of iliac crest bone biopsies have found that the spacing between bone 
structures increases with increasing age to a greater degree in females than in males. This 
increase implies that bone remodels differently for aging men than for aging women. It is 
also important to note that trabeculae are more readily resorbed than cortical bone 
(Atkinson 1967). In fact, one early feature of osteoporosis is the loss of trabecular bone 
from vertebral and pelvic bones. As resorption predominates, trabeculae are removed 
with a consequent increase in porosity, and henee a ehange in marrow eavity sizes.
The bone marrow cellularity is the pereentage of bone marrow volume occupied
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by hematopoietic cells (Gatter and Brown, 1997; Naeim, 1998). Marrow eellularity 
differs from one bone site to another and from one individual to another. Dosimetrically, 
marrow cellularity ean be defined as the percentage of bone marrow that is not fat and is 
given in Eq. 1.1. Cellularity variability greatly complicates bone dosimetry and, thus, 
requires more patient speeific methodology.
Marrow Cellularity ~ 1 -  Fat Fraction Eq 1.1
Cellularities are not constant values, but rather a function of age. At birth, nearly 
all marrow cavities are filled with aetive marrow, decreasing with age. In healthy 
individuals these rates vary with skeletal site. In the adult, active marrow is located 
primarily within the ribs, the vertebrae, and the ends of the long bones. For example, in 
the femoral head and neck average values of marrow cellularity are 100% in the 
newborn, 60% in the 10 y old child, and only 25% in the adult. In skeletal dosimetry, 
risk to the inactive marrow is of no importance, due to the lack of hematopoietic stem 
cells; therefore, some skeletal sites in the adult are of little dosimetric importance, while 
in children, risk to the same sites is an issue (ICRP 70, 1995). In radiation transport 
models, to differentiate source and target regions, active marrow is defined as the portion 
o f trabeeular marrow space not occupied by adipocytes (Bolch et al., 2002).
Skeletal Dosimetry and Alpha Particle Absorbed Fraction 
Radionuclides entering the body through the blood stream will irradiate active 
marrow in route to the organs of interest. One of the applications where the knowledge of
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the accurate value o f absorbed fraction is important is the Committed Dose Equivalent 
(CDE) described in ICRP 30. The committed dose equivalent (Hso.t) in a particular organ 
or tissue (T) is the total dose equivalent to that organ or tissue during the 50 years after 
intake o f a radionuclide. The CDE in target organ T  is given by
= 1 . 6 k 1 0 - ' “ 2 ; E
Sv Eq. 1.2
where Us is the number of transformations of nuelide j  occurring in source organ S, and 
SEE(T*r~S) is given by Eq. 1.3.
SEE(T <^S)i = ^  I - transformation^ Eq. 1.3
M j
where F, is the yield of radiation of type i per transformation, £, (in MeV) is the average 
or unique energy of radiation / as appropriate, Qi is the quality faetor appropriate for 
radiation type i, Mr (in g) is the mass of the target organ, and AF(T<—S)i is the fraction of 
energy absorbed in target organ T  from radiation i originating in S.
Chord Length Distribution Based Dosimetry Models 
The geometry and composition of the trabecular region of the skeleton creates 
several unique dosimetry problems. Since bone marrow cavities are located within the 
trabecular bone structure, the dimensions of the two interlacing regions must be 
accurately known in order to caleulate the absorbed dose to these sites. The anisotropic
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structure o f this region further eomplicates dosimetry studies in that it is difficult to apply 
any sort o f uniform modeling technique to such a complex geometry (Jokisch et al., 
1999).
This problem was first addressed at the University of Leeds by Spiers et al. 
(1976). In his work he recognized that trabecular bone dosimetry required detailed 
knowledge o f the trabecular microstructure. His group developed a method for 
performing skeletal dosimetry of eleetrons using frequeney distributions o f straight-line 
path lengths through bone and marrow regions.
A group working under W.E. Bolch at the University of Florida has obtained 
marrow and trabeculae ehord length distributions from post-mortem samples and 
surgically removed samples using nuelear magnetic resonance imaging (Jokisch et al., 
1999). By coupling measured distributions to the computer transport program. Electron 
Gamma Shower Version 4 (EGS4), the amount of energy deposited to the marrow 
eavities and trabeculae was ealeulated for eleetrons.
For a-particle transport in the skeletal tissues Watchman et al. (2005) used 
techniques similar to those developed for electrons in models published by Eckerman and 
Stabin (2000) and by Bouchet et al. (1999). In his study, a-particle transport was 
performed through the random and alternate sampling of cumulative density funetions 
(CDFs) from p-random (external) ehord-lengths across bone trabeculae and marrow 
cavities in each o f the 7 skeletal sites of the Leeds 44-y male. In ICRP Publication 30 
model values of absorbed fraction for different source-target eombination are tabulated 
only for 100% eellularity. Watchman et al. (2005) investigated eellularity effects 
(cellularity ranging from 100% to 20%) on the absorbed fraction values. Results showed
10
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that a decrease in marrow cellularity caused the values of absorbed fraction to diverge 
from the original values at 100% cellularity.
Image Based Transport Models
Jokiseh et al. (1999) developed a voxel array transport methodology in which 
segmented NMR images of trabecular bone was used as the basis for the transport 
geometry within EGS. In this transport model, a region of interest was coupled to the 
EGS4 voxel array transport code. When a particle left the region, it was reintroduced 
back into the image. A very unique aspect o f skeletal dosimetry, utilizing voxelized 
images, is that target region masses and absorbed fractions can be measured from the 
same sample.
There are several differences between image based and chord based radiation 
transport models of a-particles. All chord distribution based models rely on a few basic 
assumptions. These models assume that chord length distributions in bone and marrow 
are independent of one other. A chord length model randomly samples from both, the 
marrow and bone distributions. However, there may be an association between the 
occurrence of chords of given lengths. This seems likely upon visual examination of an 
image of a trabecular region, where different regions appear to have different 
eharacteristics. In his earlier work, Jokisch et al. (1999) showed that bone and marrow 
chord lengths are not statistically independent.
In a voxelized image based model, particles are introduced into the image, thus, 
providing all original characteristies of the bone site. The a-particle energy loss through
11
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the image is calculated for each and every voxel crossed by the particle during the 
transport.
One major eoncem with alpha transport in voxelized images are the effects 
associated with the representation o f the spherical microstructures as eubes. 
Consequently, the interface between bone and marrow is represented by the straight 
surface, which in real bone geometry may be complexly curved; therefore, the distance 
traveled by an a-particle in each tissue will be determined by the resolution o f the image.
The ICRP Publication 30 Bone Model
At present, absorbed fraction values for a-particles in skeletal tissues are only 
standardized in two sources: ICRP Publication 30 (1979) and the 2003 Eckerman model 
used in the OLINDA code (Stabin and Sparks, 2003). The ICRP Publication 30 bone 
model, developed to provide a conservative dosimetric framework for radiation 
protection of the skeletal tissues, gives values of a-particle absorbed fractions which are 
independent of both particle energy and skeletal site. In the 2003 Eckerman model, 
energy dependence was introduced for some source-target tissue combinations, while for 
others, values from the ICRP 30 model were adopted. The influence o f marrow 
cellularity on values o f absorbed fraction is also not considered either. Table 1.2 shows 
the values of absorbed fraction adapted in the ICRP 30 model. ICRP Publication 30 along 
with the trabecular bone volume source, considérés the bone surface as a source region, 
however this source is not investigated in this work. Additionally, both ICRP Publication 
30 and Eckerman bone models assign an absorbed fraction value of 1.0 for the self 
irradiation considering all targets and regardless of the energy of the a-partiele.
12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1.2. Recommended a-particle absorbed fractions for dosimetry o f radionuclides in




The goal of this study is to calculate absorbed fractions for different target-source 
eombinations and for various cellularities and to determine the energy and eellularity 
dependence of energy deposition within the TAM, TAMs, and TBV. The 3D voxelized 
image based transport will be performed on 33 microCT images of different skeletal sites. 
In addition, absorbed fraction values for TAM, TAMs, and TBV for bone regions with 
similar anatomical features (i.e. right and left femur head, ete.) will be weighted by the 
volume fraetion of each image and then averaged. For example, the absorbed fraction to 
the cranium would be the sum of the absorbed fractions from all bone sites of the cranium 
(frontal, occipital, mandible, and parietal bones) scaled by their volume fractions. Alpha- 
particle absorbed fractions will be calculated for energies from 3 MeV up to 15 MeV and 
will be eompared to the energy-independent ICRP 30 values. Cellularities will vary from 
100% to 10% and their effeets on absorbed fraction values will be investigated for all 
source-target eombinations. It also will be shown if absorbed fractions calculated in this 
study for various cellularitis diverge from the values assumed by the ICRP 30. Previous 
studies show that radiosensitive progenitor cells are located as deep as 50 pm from the 
trabecular bone surfaee (Yin and Li, 2006; Hayloek and Nilsson, 2006); therefore, we 
will eonsider a shallow marrow layer as a source and target region in our caleulations.
13
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CHAPTER 2
MATERIALS AND METHODS
Alpha particle transport in the skeletal tissue is accomplished using techniques 
similar to those developed for electrons in models by Jokisch et al. (1999) and Patton et 
al. (2002). The unique feature of the present model is adaption of a-particle transport to 
voxelized 3D images. Through the use of range-energy relationships (ICRP 30, 1979), 
absorbed fractions to deep marrow (TAM), shallow marrow (TAMs), inactive marrow 
(TIM), and the trabecular bone volume (TBV) are calculated for a-particle emissions 
from 3 MeV up to 15 MeV (energies of interest in a-radiotherapy). The region of interest 
is selected within the trabecular spongiosa; therefore, alpha transport is performed only 
within the ROI (marrow, shallow marrow and bone trabeculae) and the particle is 
reintroduced back to the ROI every time it leaves the volume. While this assumption is 
rarely valid for high energy beta particles in the skeleton (Patton et al., 2002), the model 
is considered to be quite adequate for high energy a-particles (Watchman et al., 2005).
Image Acquisition and Processing
All images used in this study were previously acquired and proeessed by Shah et 
al. (2005). A 66 year old male eadaver was purchased from the State of Florida 
Anatomical Board and taken to Shands Hospital for imaging on a General Eleetric 
LightSpeed QX/i Computed Tomography seanner operating at 120 kV and 120 mAs.
The images obtained at the University of Florida have 256 gray levels with a
14
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value of 0 corresponding to a black voxel, and a value of 255 corresponding to a white 
voxel. Four image-processing steps were performed prior to using the image for 
subsequent dosimetric calculations. These steps include (1) visual inspection of the 
image, (2) determination of optimal image threshold value, (3) image segmentation, and 
(4) image filtering (Shah et al., 2005).
Visual inspeetion of the image determines if any problems occurred during image 
acquisition. Image thresholding and bone segmentation steps require that a gray-level 
intensity histogram of the voxels be produced from a ROI of each image. Sinee the 
images ideally represent only two media (bone trabeculae and marrow), the histogram 
would ideally contain only two peaks: one representing bone voxels (lower intensity 
peaks) and one representing marrow space voxels (higher intensity peaks). The marrow 
eavities and the bone trabeculae are separated by assigning a gray-level threshold. As a 
result, the image is effeetively segmented only into bone and marrow voxels (Shah et al., 
2005).
The single and double voxels o f anomalously high or low intensity which arise 
from signal noise after image segmentation are eliminated by image filtering step. A 
weighted-median filter reassigns the gray level of the voxel being evaluated unless two or 
more adjacent voxels have the same gray level value (Shah et al., 2005).
Tissue Composition and Range-Energy Data
The model developed in this work utilizes range-energy data calculated using 
elemental compositions and mass densities for the tissues o f the trabecular spongiosa 
(ICRU 46, 2000), where range-energy functions for active marrow, inactive marrow and
15
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trabecular bone were calculated using the Bragg-Kleeman rule (Knoll, 2000) with liquid 
water and compact bone, as the reference media for range scaling. Tabular data for the 
CSDA range versus particle energy for all tissues is given in Appendix A. Intermediate 
values for the ranges were assessed via interpolation of tabular values. Several funetions 
were written to interpolate range-energies for different tissue. These values are used for 
the calculation of energy loss in each voxel and, thus, for the calculation of absorbed 
fraction in the given skeleton site for different source-target combinations.
Methods for Target Region Mass Measurement
A very unique aspect of skeletal dosimetry utilizing any three-dimensional 
imaging modality is that target region masses and absorbed fractions can be measured 
from the same sample. All mass measurements can be based on the same ROI o f the 
image, within which the radiation transport was performed. The number o f bone and 
marrow voxels in the ROI, along with the voxel dimensions, determines the total volume 
of bone and marrow within each image. Multiplying this bone volume by the density of 
adult cortical bone (1.92 g cm^), yields the total trabecular bone volume (TBV) mass, 
therefore, also the total marrow space (TMS) mass.
In this study, the total marrow space (TMS) is further subdivided into shallow 
marrow (TAMs), deep marrow (TAM), and inactive marrow (TIM). The shallow marrow 
region is located inside the marrow space on the bone surface where radiosensitive 
progenitor cells are located. Several studies show that these cells are located within “bone 
niches” (Yin and Li, 2006) forming a so called “bridge between bone and blood” 
(Hayloek and Nilsson, 2006). Osteoblasts are one of the most functionally important
16
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progenitor eells in the bone. Osteoblasts are located mainly on the bone surface and 
occupy 25 -  50 pm of bone niches, due to the diameter of these cells; therefore, in our 
calculations, the shallow marrow region is assumed to be 50 pm thick. The rest o f the 
marrow space is occupied by active marrow known as deep marrow. Finally, for 
calculations with various cellularities, adipose tissue is randomly introduced into the 
TMS.
To determine the mass of the trabecular bone volume (TBV) and active marrow 
(TMS), the number of voxels of each TBV and TMS in the image are multiplied by the 
dimensions of the voxels and the density o f each tissue type. To determine the mass of 
TAMs, the number of bone/marrow voxel sides must first be determined. Multiplying the 
number of sides by the 60 x 60 x 50 pm and the density o f marrow (1.03 g/cm^) gives the 
mass of shallow marrow. Mass of the deep marrow (TAM) is ealeulated by subtraction of 
the shallow marrow mass from the active marrow mass. Table 2.1. shows masses of 
different target tissues TAM, TAMs, and TBV for all 33 bone sites at 100% eellularity.
Model for Voxelized Image Transport
Alpha-partiele transport was performed by randomly picking a starting point and 
direction inside a ROI in each of the 33 different skeletal sites. The code sampled a 
random point inside the image in order to find the starting tissue of interest. Once the 
starting point wass determined, a-partieles were transported in the random direction 
inside this region to the nearest voxel boundary. Each CT image was composed of an 
array of 60 x 60 x 60 pm^ voxels. For each voxel in the image one o f two media
17
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Table 2.1. Masses of different target tissues o f deep marrow (TAM), shallow marrow
Mass (g)
Bone Sites TAM TAMs TBV
Right Femur Head 0.605 0.178 0.797
Left Femur Head 1.506 0.329 1.418
Left Femur Neck 1.673 0.190 0.454
Right Femur Neck 2.297 0.220 0.543
Left Parietal Bone 0.289 0.075 0.356
Right Parietal Bone 1.103 0.292 1.443
Frontal Bone 0.756 0.249 1.271
Occipital Bone 0.123 0.046 0.267
Mandible &896 0.099 0.366
Sternum 1.994 0.214 0.413
Right Humerus Z222 0.325 0.924
Left Humerus 2.958 0.568 L868
C3 Vertebra 0.560 0.077 0.141
C6 Vertebra 0.745 0.128 0.267
T3 Vertebra 2.149 0.267 0.500
T6 Vertebra 2.291 0.212 0385
T11 Vertebra 1.876 0.431 1.342
L2 Vertebra 1.613 0.161 0389
L4 Vertebra 0.874 0.196 0.592
Sacrum 1.431 0.207 0.432
Right Clavicle 0.529 0.079 0.277
Left Clavicle 0.400 0.022 0.031
Pelvis Pubis 2.551 0.302 0.698
Pelvis Ischium 1.753 0.144 0.296
Pelvis Ilium Z329 0.291 0.620
Right Scapula 0.630 0.084 0.294
Left Scapula 0.504 0.058 0.147
Upper Right Rib 0.198 0.021 0.065
Middle Right Rib 0.489 0.030 0.061
Lower Right Rib 0.217 0.022 0.042
Upper Left Rib 0.189 0.018 0.030
Middle Left Rib 0.575 0.043 &088
Lower Left Rib 0.138 0.011 0.017
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was assigned: marrow or bone tissue. To investigate the effect of cellularity on absorbed 
fractions, marrow was divided into active and inactive marrow. Calculations were 
performed for cellularity values of 100, 90, 70, 50, 30, and 10 percent. Results were 
interpolated for 80, 60, 40 and 20 percent cellularities.
The distance traveled in each voxel was calculated during the transport using the 
straight line path between starting position and the nearest boundary in the direction of 
travel o f the a-particle. Energy deposition in each tissue type was calculated based on the 
distance traveled in each voxel. If the range of the a-particle was less than the distance 
required to exit the voxel, the entire kinetic energy o f the a-particle was deposited inside 
that voxel, otherwise, if  the range was more than the distance to exit the voxel, the 
amount o f energy deposited within the voxel was determined by calculating the kinetic 
energy o f the a-particle entering the voxel and exiting the voxel, using range-energy 
relationships. The particle was then transported aeross the next voxel. This process was 
repeated until the particle’s energy reached 0.001 MeV, following which the remaining 
energy was locally deposited.
Scoring energy deposition within the shallow marrow layer on the surfaces of 
trabeculae required a special subroutine shown in Appendix B. When energy deposition 
took place within a marrow voxel, it was determined if the marrow voxel bordered a bone 
voxel. If the marrow voxel was not adjacent to the bone surface, the full energy 
deposition was scored to the deep marrow (TAM). If the event occurred within a marrow 
surface o f thevoxel, a shallow marrow distance scoring algorithm was called. If the 
energy-loss event to bone surface distance was less than 50 pm, part of the a-particle 
energy was deposited to the shallow marrow and the remaining kinetic energy, if any.
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was deposited to the deep marrow. Otherwise, the energy deposition was scored strictly 
to the marrow tissues. In the case where the particle crossed the shallow marrow region, 
some portion was deposited to the deep marrow and the rest to the shallow marrow. This 
scoring was performed by comparing the actual distance traveled by the a-particle within 
the marrow voxel and the distance that the same particle would travel to the boundary of 
that voxel for a given starting position and the given angle.
All results shown in this work were for 10 runs o f 100,000 particles (1,000,000 
total histories). The time of one run (one source, four targets, and energies from 3 to 15 
MeV with 1 MeV increment) was ~I5 min on Intel Duo 1.83 GHz workstation. Mean 
absorbed fractions and standard deviations were calculated at the 95% confidence level. 
Coefficients o f variation on the absorbed fractions were typically less than 1%. Thirty 
three pCT images of different skeletal sites were used for alpha transport and results of 
absorbed fractions for different source-target combination of TAM, TAMs, and TBV 
were calculated for energies up to 15 MeV. The bone sites and matrix sizes associated 
with these images are given in Table 2.2.
In addition, absorbed fraction values for TAM, TAMs, and TBV for bone regions 
with multiple bone site ROls (i.e. right and left femur head, etc.) have been weighted by 
the volume fraction of each image and then averaged. For example, the absorbed fraction 
to the cranium is the sum of the absorbed fractions from all bone sites of the cranium 
(frontal, occipital, mandible, and parietal bones) scaled by their volume fractions. 
Absorbed fractions were averaged for vertebrae, femur (head and neck), parietal bone, 
cranium, ribs, scapula, and clavicle.
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Table 2.2. List o f  the image dimensions (Height, Width, and Depth) o f  the 33 microCT
images used in this study.___________________________________________________________
Matrix Dimensions
Bone Site Height Width Depth
Right Femur Head 165 100 330
Left Femur Head 180 180 360
Left Femur Neck 185 160 320
Right Femur Neck 185 175 390
Left Parietal Bone 75 185 180
Right Parietal Bone 90 285 380
Frontal Bone 70 285 380
Occipital Bone 65 60 360
Mandible 85 225 280
Sternum 400 210 130
Right Humerus 410 230 145
Left Humerus 240 265 320
C3 Vertebra 125 135 190
C6 Vertebra 150 210 145
T3 Vertebra 225 195 275
T6 Vertebra 180 330 205
T11 Vertebra 160 210 405
L2 Vertebra 170 340 150
L4 Vertebra 145 215 200
Sacrum 200 175 240
Right Clavicle 270 70 180
Left Clavicle 60 235 140
Pelvis Pubis 260 180 310
Pelvis Ischium 280 100 330
Pelvis Ilium 610 145 150
Right Scapula 400 70 140
Left Scapula 145 75 265
Upper Right Rib 380 60 50
Middle Right Rib 295 80 105
Lower Right Rib 395 85 35
Upper Left Rib 70 65 220
Middle Left Rib 100 65 460
Lower Left Rib 100 75 95
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CHAPTER 3
RESULTS AND DISCUSSION 
Convergence Factors for Different Target Regions 
Since this study considers a-particle transport only within infinite trabecular bone 
regions, the particle is reintroduced back into the image when it reaches the edge, and the 
new voxel medium is determined by the medium of the voxel the particle exited. As a 
result, with increasing particle initial energy the absorbed fractions for each o f the three 
target tissues should approach target-specific convergence values that depend on the mass 
fraction of the irradiated tissue.
The absorbed fraction to the trabecular marrow space for an a-particle emitted 
from source region, S, may be expressed in terms of the masses within the trabecular 
bone site (Patton et al., 2002):
A F (T M S < -S ) = ----------------------------------- r------- Eq. 3.1
^ T A M  ^ T A M s t f Î T B V
V /  A c ,T B V
where mrxM, hitams, and mysv are the masses of the deep marrow, shallow marrow, and 
trabecular bone volume, respectively, within the skeletal site, and (d T /p d x )c  is the
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collisional mass stopping power for either hone tissue (TBV) or soft tissue (TAM or 
TAMs). Equation 3.1 can alternatively be expressed in terms o f regional volumes within 
the skeletal site (Patton et al., 2002);
AF(TM S <- 5) = ---------------------------------  r------  Eq. 3.2
^ T A M  ^TA M s ^TBV
Similar expressions for the convergence values to the TAM, TAMs, and TBV as target 
regions can be derived.
To verify the user written alpha transport code, absorbed fraction values are 
calculated for a-particles with initial kinetic energy ranging from 3 MeV to 300 MeV for 
all source-target combinations. Figure 3.1 shows the absorbed fraction values within a) 
TAM, b) TAMs, and c) TBV for the different source regions of the frontal bone. It can be 
seen that a t -110 MeV the absorbed fractions start to approach their convergence values 
(0.39 for TAM, 0.12 for TAMs, and 0.49 for TBV) independent o f the source. However, 
calculations were made up to 300 MeV to determine the accuracy of convergence. Table 
3.1 lists the absorbed fraction values for different source-target combination at 300 MeV, 
convergence values, and the percent error of these values for the frontal bone, upper left 
rib, and 3'^ '^  cervical vertebra. We can see that calculated values of absorbed fraction vary 
for all bone sites. The maximum percent error is 3.03% for upper left rib. The average 
percent error for all three bone sites and for all source-target combinations is 0.92%. 
Absorbed fractions acquired at higher energies lay within the same percent error of the
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Figure 3.1. Absorbed fraction convergence values within frontal bone for various target 
tissues and sources in a) deep marrow (TAM), b) shallow marrow (TAMs), c) and 
trabecular bone volume (TBV).
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Table 3.1. List of absorbed fractions and convergence values calculated for different 
source-target combinations at 300 MeV within the frontal bone, upper left rib, and
cervical vertebra._______________________________________________________________
Frontal Bone
Source-Targets ^ ^ e V ^ ^  Covergence Values % error
AF(TA M ^TA M ) 0.385 0.386 0.26
AF(TAM ^TAM s) 0.383 0.386 0.78
AF(TAM-h-TBV) 0.381 0.386 1.31
AF(TAM s^TAM ) 0.118 0.119 0.85
AF(TAMs+-TAMs) 0.118 0.119 0.85
AF(TAMs-s-TBV) 0.118 0.119 0.85
A F(TBV^TA M ) 0.496 0.493 0.61
AF(TBV^TAM s) 0.498 0.493 1.01
AF(TBV*-TBV)_____________________ 0.499____________0.493__________ 1.22
Upper Left Rib
A F(TAM ^TAM ) 0.834 0.831 0.36
AF(TAM ^TAM s) 0.831 0.831 0.00
AF(TAM<-TBV) 0.829 0.831 0.24
AF(TAM s^TAM ) 0.065 0.066 1.54
AF(TAM s^TAM s) 0.067 0.066 1.52
A F(TAM s^TBV) 0.067 0.066 1.52
AF(TBV<-TAM) 0.099 0.102 3.03
A F(TBV^TAM s) 0.101 0.102 0.99
AF(TBV<-TBV)_____________________ 0.103____________0.102__________ 0.98
3"^  ^Cervical Vertebra 
AF(TA M ^TA M ) 0.759 0.757 0.26
AF(TAM ^TAM s) 0.756 0.757 0.13
AF(TA M ^TBV ) 0.753 0.757 0.53
AF(TAM s^TAM ) 0.093 0.093 0.00
AF(TAMs<-TAMs) 0.094 0.093 1.08
A F(TAM s^TBV) 0.094 0.093 1.08
A F(TBV^TA M ) 0.146 0.149 2.05
AF(TBV^TAM s) 0.148 0.149 0.68
AF(TBV-i-TBV)_____________________ 0.151____________0.149__________ 1.34
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convergence values due to minor inaccuracies associated with statistical errors o f the 
Monte Carlo transport model. The work presented above provides verification o f the 
aeeuracy of this model.
Absorbed Fraction to Bone Marrow 
Absorbed Fraction to Deep Marrow 
Figure 3.2 displays values of absorbed fraetions to TAM as a function of a- 
particle kinetic energy within 3 skeletal sites (cranium, ribs and sacrum) for sources 
located in TAM, TAMs and TBV. In each case, the marrow cellularity is 100%. Thus, 
differences in energy dependence of the absorbed fractions are strictly related to 
differences in the trabecular microstructure o f these bone sites.
The absorbed fractions for the irradiation of the deep marrow, AF(TAM<—TAM), 
are shown in Fig. 3.2 for the cranium, ribs, and sacrum (values of absorbed fraction are 
averaged for all bone sites of the skull, all ribs, ete.). At low energies, the 
AF(TAM<—TAM) in all bone sites start at -1 .0  (3 MeV) and, thus, are closely 
approximated by the energy-independent value assumed under the ICRP Publieation 30 
model. As the particle energy increases, an increasing amount of kinetic energy is lost to 
the bone trabeculae and shallow marrow, leaving less energy available for deposition to 
bone marrow. However, at 15 MeV, the AF(TAM<—TAM) for the cranium is 0.83, for 
the ribs is 0.95, and for the sacrum is 0.90. Table 3.2 shows the averaged absorbed 
fraction values of TAM irradiating a TAM for all bone sites. The cranium demonstrates 
the greatest divergence from the other bone sites and from the ICRP Publication 30 
model at all energies (0.98 at 3 MeV and 0.83 at 15 MeV), as this particular bone site is
26
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Figure 3.2. Absorbed fraction within deep marrow target of cranium, ribs and sacrum 
for sources in TAM, TAMs, and TBV.
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Table 3.2. Absorbed fraction values for self-irradiation o f deep marrow (TAM) for all
bone sites and for 100% cellulaities.
AF(TAM<--TAM)
Energy (MeV) Cranium Ribs Femur Flumerus Pelvis
3 9.84E-01 9.95E-01 9.89E-01 9.89E-01 9.92E-01
4 9.76E-01 9.92E-01 9.83E-01 9.83E-01 9.88E-01
5 9.67E-01 9.89E-01 9.77E-01 9.77E-01 9.84E-01
6 9.57E-01 9.86E-01 9.69E-01 9.70E-01 9.79E-01
7 9.47E-01 9.82E-01 9.62E-01 9.63E-01 9.74E-01
8 9.36E-01 9.79E-01 9.54E-01 9.55E-01 9.68E-01
9 9.24E-01 9.75E-01 9.46E-01 9.47E-01 9.63E-01
10 9.11E-01 9.71E-01 9.37E-01 9.37E-01 9.57E-01
11 8.97E-01 9.67E-01 9.26E-01 9.27E-01 9.50E-01
12 8.83E-01 9.63E-01 9.17E-01 9.17E-01 9.43E-01
13 8.68E-01 9.58E-01 9.06E-01 9.07E-01 9.36E-01
14 8.52E-01 9.54E-01 8.95E-01 8.96E-01 9.29E-01
15 8.37E-01 9.50E-01 8.84E-01 8.85E-01 9.22E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 9.92E-01 9.94E-01 9.90E-01 9.90E-01 9.92E-01
4 9.88E-01 9.90E-01 9.84E-01 9.85E-01 9.88E-01
5 9.83E-01 9.87E-01 9.79E-01 9.79E-01 9.84E-01
6 9.78E-01 9.83E-01 9.72E-01 9.73E-01 9.79E-01
7 9.73E-01 9.79E-01 9.65E-01 9.67E-01 9.74E-01
8 9.68E-01 9.74E-01 9.58E-01 9.60E-01 9.69E-01
9 9.61E-01 9.69E-01 9.51E-01 9.53E-01 9.64E-01
10 9.55E-01 9.64E-01 9.43E-01 9.45E-01 9.58E-01
11 9.48E-01 9.58E-01 9.33E-01 9.36E-01 9.52E-01
12 9.41E-01 9.53E-01 9.25E-01 9.28E-01 9.46E-01
13 9.34E-01 9.47E-01 9.15E-01 9.19E-01 9.39E-01
14 9.27E-01 9.42E-01 9.05E-01 9.09E-01 9.32E-01
15 9.20E-01 9.36E-01 8.96E-01 9.00E-01 9.26E-01
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characterized by relatively small marrow cavities and thick bone trabeculae. The smallest 
difference from the ICRP Publication 30 model is demonstrated by the ribs, which are 
characterized by relatively large marrow cavities and thin bone trabeculae. Absorbed 
fraction values for this particular bone site are 0.99 at 3 MeV and 0.95 at 15 MeV.
Figure 3.2 also shows absorbed fractions to TAM from a TAMs source within the 
cranium, ribs, and sacrum. At low energies (3 MeV), values of AF(TAM<—TAMs) start 
at 0.07 for the cranium and -0.08 for the ribs and sacrum. Absorbed fraction values at 15 
MeV are 0.36, 0.45, and 0.51 for the cranium, sacrum, and ribs, respectively. When the 
energy increases, absorbed fraction values increase with the same pattern for all bone 
sites. Table 3.3 shows the absorbed fraction values of TAMs irradiating a TAM for all 
bone sites. The largest value of AF(TAM<—TAMs) at 3 MeV is 0.083 in the sternum. At 
15 MeV, ribs demonstrate the greatest difference from the other bone sites with an 
absorbed fraction value of 0.51. The smallest value of absorbed fraction is seen in 
occipital bone at all energies (0.066 at 3 MeV and of 0.32 at 15 MeV). This source region 
is not discussed in the ICRP 30 bone model. However, this study suggests that a TAMs 
source region should be considered in future dosimetric models due to the high energy 
dependence of the AF(TAM<—TAMs) values.
Finally, Fig. 3.2 shows values of AF(TAM<—TBV) within the cranium, ribs, and 
sacrum. Values of AF(TAM<—TBV) are shown to start at zero and increase with a- 
particle kinetic energy, as expected. At 15 MeV, AF(TAM<—TBV) for the cranium is 
0.084, for the ribs is 0.14, and for the sacrum is 0.19. Table 3.4 shows the absorbed 
fraction values of TBV irradiating a TAM for all bone sites. The cranium has the smallest 
AF at 15 MeV (0.08), while the sternum has the largest (0.19). The ICRP Publication
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Table 3.3. Absorbed fractions to TAM for the a-particle emission within TAMs for all
bone sites and for 100% cellulaities.
AF(TAM ^-TAMs)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 7.00E-02 7.95E-02 7.62E-02 7.53E-02 8.16E-02
4 1.05E-01 1.20E-01 1.14E-01 1.13E-01 1.22E-01
5 1.44E-01 1.67E-01 1.56E-01 1.54E-01 1.67E-01
6 1.83E-01 2.17E-01 1.99E-01 1.97E-01 2.14E-01
7 2.19E-01 2.68E-01 2.39E-01 2.36E-01 2.58E-01
8 2.51E-01 3.15E-01 2.75E-01 2.71E-01 2.98E-01
9 2.78E-01 3.57E-01 3.06E-01 3.00E-01 3.33E-01
10 3.01E-01 3.92E-01 3.33E-01 3.26E-01 3.63E-01
11 3.22E-01 4.26E-01 3.58E-01 3.51E-01 3.93E-01
12 3.36E-01 4.51E-01 3.77E-01 3.70E-01 4.16E-01
13 3.49E-01 4.74E-01 3.94E-01 3.86E-01 4.37E-01
14 3.59E-01 4.95E-01 4.09E-01 4.01E-01 4.57E-01
15 3.66E-01 5.11E-01 4.21E-01 4.13E-01 4.74E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 7.78E-02 7.76E-02 7.84E-02 7.93E-02 8.35E-02
4 1.17E-01 1.17E-01 1.17E-01 1.19E-01 1.25E-01
5 1.60E-01 1.62E-01 1.61E-01 1.63E-01 1.71E-01
6 2.06E-01 2.10E-01 2.05E-01 2.08E-01 2.18E-01
7 2.49E-01 2.58E-01 2.47E-01 2.49E-01 2.64E-01
8 2.88E-01 3.03E-01 2.86E-01 2.87E-01 3.04E-01
9 3.22E-01 3.43E-01 3.19E-01 3.20E-01 3.39E-01
10 3.51E-01 3.76E-01 3.47E-01 3.49E-01 3.70E-01
11 3.79E-01 4.07E-01 3.75E-01 3.77E-01 4.00E-01
12 3.99E-01 4.31E-01 3.96E-01 3.97E-01 4.24E-01
13 4.18E-01 4.52E-01 4.15E-01 4.17E-01 4.47E-01
14 4.35E-01 4.71E-01 4.33E-01 4.35E-01 4.67E-01
15 4.48E-01 4.86E-01 4.47E-01 4.50E-01 4.84E-01
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Table 3.4. Absorbed fractions to TAM for the a-particle emission within TBV for all
bone sites and for 100% cellulaities.
AF(TAM^-TBV)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 3.76E-04 6.53E-04 6.01E-04 6.19E-04 8.60E-04
4 9.09E-04 1.57E-03 1.46E-03 1.51E-03 2.09E-03
5 1.87E-03 3.21E-03 2.96E-03 3.03E-03 4.25E-03
6 3.55E-03 5.98E-03 5.60E-03 5.78E-03 7.86E-03
7 6.28E-03 1.04E-02 9.79E-03 l.OlE-02 1.37E-02
8 l.OlE-02 1.70E-02 1.57E-02 1.63E-02 2.22E-02
9 1.59E-02 2.73E-02 2.49E-02 2.57E-02 3.50E-02
10 2.37E-02 4.09E-02 3.71E-02 3.86E-02 5.21E-02
11 3.39E-02 5.84E-02 5.29E-02 5.53E-02 7.40E-02
12 4.48E-02 7.72E-02 6.95E-02 7.28E-02 9.72E-02
13 5.72E-02 9.82E-02 8.86E-02 9.30E-02 1.23E-01
14 7.13E-02 1.22E-01 l.lOE-01 1.15E-01 1.52E-01
15 8.49E-02 1.44E-01 1.30E-01 1.38E-01 1.80E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 5.77E-04 6.28E-04 8.57E-04 9.27E-04 9.90E-04
4 1.40E-03 1.50E-03 2.05E-03 2.23E-03 2.35E-03
5 2.88E-03 3.05E-03 4.17E-03 4.60E-03 4.81E-03
6 5.37E-03 5.69E-03 7.82E-03 8.40E-03 8.87E-03
7 9.42E-03 9.93E-03 1.36E-02 1.47E-02 1.54E-02
8 1.52E-02 1.62E-02 2.20E-02 2.38E-02 2.46E-02
9 2.39E-02 2.59E-02 3.52E-02 3.76E-02 3.92E-02
10 3.57E-02 3.87E-02 5.26E-02 5.58E-02 5.83E-02
11 5.09E-02 5.52E-02 7.50E-02 7.94E-02 8.21E-02
12 6.67E-02 7.28E-02 9.86E-02 1.04E-01 1.07E-01
13 8.49E-02 9.24E-02 1.25E-01 1.32E-01 1.35E-01
14 1.05E-01 1.14E-01 1.55E-01 1.63E-01 1.65E-01
15 1.26E-01 1.36E-01 1.84E-01 1.94E-01 1.94E-01
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30 model applies an energy-independent value, 0.05, for this source-target combination. 
This work shows values of AF(TAM<—TBV) less then 0.05 at a-energies below ~ 9 MeV 
for all bone sites, with higher absorbed fractions to bone marrow seen at energies 
exceeding 11 MeV. The absorbed fraction values to TAM for all sources and all 33 pCT 
bone sites are shown in Appendix C (tables) and Appendix D (graphs).
Absorbed Fraction to Shallow Marrow Region 
Figure 3.3 displays values of absorbed fraction to TAMs as a function of a- 
particle kinetic energy for the previously mentioned skeletal sites and for sources located 
in TAM, TAMs and TBV.
For emissions within TAM, values of AF(TAMs-<—TAM) acquired from this 
study start at zero (3 MeV), in all bone sites, and increase to values of 0.031, 0.055, and 
0.082 at 15 MeV in the ribs, sacrum, and cranium, respectively. Table 3.5 shows the 
absorbed fraction values of TAM irradiating a TAMs for all bone sites. At high energies 
(15 MeV), the largest absorbed fraction value is 0.1 for the occipital bone, and the 
smallest value at the same energy is 0.031 for the ribs. The TAM source results in the 
smallest absorbed fractions to the TAMs target due to the low number of TAMs layers. 
These numbers are specified by the trabecular bone microstructure. The TAMs region is 
not considered in the ICRP 30 bone model. However, our study suggests that the 
radiosensitive TAMs layer should be considered for inclusion along with the endosteal 
layer discussed in ICRP Publication 30.
From Fig. 3.3, values o f AF(TAMs<—TAMs) at 3 MeV start at -0.86 -  0.87, for 
all bone sites (including sacrum, ribs and cranium). At 15 MeV, these values decrease to 
0.25 for the cranium, 0.26 for the sacrum, and 0.27 for the ribs. The absorbed fractions
32
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Figure 3.3. Absorbed fraction within shallow marrow for different bone sites and 
sources in a) TAM, b) TAMs, and c) TBV.
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Table 3.5. Absorbed fractions to TAMs for the a-particle emission within TAM for all
bone sites and for 100% cellularities.
AF(TAM s^TAM )
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 1.56E-02 5.11E-03 1.12E-02 l.llE -0 2 7.75E-03
4 2.30E-02 7.56E-03 1.64E-02 1.62E-02 1.14E-02
5 3.11E-02 1.03E-02 2.23E-02 2.20E-02 1.55E-02
6 3.97E-02 1.34E-02 2.85E-02 2.81E-02 1.98E-02
7 4.82E-02 1.65E-02 3.47E-02 3.41E-02 2.41E-02
8 5.60E-02 1.93E-02 4.01E-02 3.96E-02 2.78E-02
9 6.22E-02 2.18E-02 4.46E-02 4.40E-02 3.11E-02
10 6.72E-02 2.39E-02 4.83E-02 4.80E-02 3.39E-02
11 7.20E-02 2.60E-02 5.21E-02 5.15E-02 3.68E-02
12 7.54E-02 2.76E-02 5.48E-02 5.45E-02 3.91E-02
13 7.82E-02 2.90E-02 5.73E-02 5.70E-02 4.10E-02
14 8.06E-02 3.03E-02 5.95E-02 5.93E-02 4.31E-02
15 8.21E-02 3.15E-02 6.11E-02 6.11E-02 4.48E-02
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 7.93E-03 6.27E-03 1.02E-02 9.80E-03 7.64E-03
4 1.17E-02 9.26E-03 1.50E-02 1.45E-02 1.12E-02
5 1.59E-02 1.26E-02 2.04E-02 1.97E-02 1.52E-02
6 2.03E-02 1.63E-02 2.60E-02 2.50E-02 1.93E-02
7 2.49E-02 2.00E-02 3.16E-02 3.04E-02 2.35E-02
8 2.87E-02 2.35E-02 3.66E-02 3.52E-02 2.71E-02
9 3.24E-02 2.62E-02 4.08E-02 3.92E-02 3.04E-02
10 3.52E-02 2.89E-02 4.45E-02 4.27E-02 3.30E-02
11 3.80E-02 3.13E-02 4.81E-02 4.62E-02 3.59E-02
12 4.03E-02 3.32E-02 5.07E-02 4.89E-02 3.79E-02
13 4.21E-02 3.49E-02 5.35E-02 5.15E-02 3.99E-02
14 4.41E-02 3.60E-02 5.58E-02 5.41E-02 4.22E-02
15 4.55E-02 3.74E-02 5.77E-02 5.59E-02 4.37E-02
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for the self-irradiation of the shallow marrow approach values o f -0.25 -  0.27 at 15 MeV, 
for all bone sites. As a result, the AF(TAMs<—TAMs) reaches the maximum values at 
low energies. At higher energies (15 MeV), the AF(TAMs*—TAMs) values are 
predetermined by the bone microstructure and increase with the a-particle kinetic energy. 
Table 3.6 shows the AF(TAMs*—TAMs) for all bone sites.
Values of AF(TAMs<—TBV) are shown in Fig. 3.3. Again the absorbed fractions 
start at zero and increase to 0.09 for the cranium, 0.13 for the ribs, and 0.17 for the 
sacrum at 15 MeV. Table 3.7 shows these absorbed fraction values for all bone sites. At 
15 MeV, the smallest value o f AF(TAMs*—TBV) is in the bones of the cranium (0.087 in 
the occipital, 0.094 in the mandible, 0.097 in the frontal, and 0.1 in the parietal, 
respectively) which result in an average absorbed fraction value of 0.096 to the cranium. 
The largest value of AF(TAMs*—TBV) at 15 MeV is 0.17 in the sacrum. Results show 
that TBV also distributes a portion of the a-particle kinetic energy to a TAMs region; 
therefore, AF(TAMs*—TBV) should be considered in future dosimetric models. The 
absorbed fraction values to all 33 pCT bone samples and all 3 sources are shown in 
Appendix C (tables) and Appendix D (graphs).
Absorbed Fractions to Trabecular Bone Region 
Figure 3.4 displays values of absorbed fraction to the TBV as a function of a- 
particle kinetic energy in the previously mentioned bone sites for sources located in 
TAM, TAMs and TBV.
For emissions within the TAM, values of AF(TBV*—TAM) acquired from this 
study start at zero (3 MeV) and approach 0.018, 0.043, and 0.081 (15 MeV) for the ribs, 
sacrum, and cranium, respectively. Values o f AF(TBV*—TAM) from all bone sites reach
35
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Table 3.6. Absorbed ffaetion values for self-irradiation o f shallow marrow (TAMs) for
all bone sites and for 100% cellularities.
AF(TAMs*- TAMs)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 8.65E-01 8.78E-01 8.63E-01 8.62E-01 8.63E-01
4 7.97E-01 8.16E-01 7.94E-01 7.93E-01 7.94E-01
5 7.20E-01 7.45E-01 7.17E-01 7.16E-01 7.17E-01
6 6.41E-01 6.69E-01 6.37E-01 6.36E-01 6.37E-01
7 5.66E-01 5.93E-01 5.61E-01 5.60E-01 5.60E-01
8 4.98E-01 5.23E-01 4.93E-01 4.92E-01 4.93E-01
9 4.44E-01 4.65E-01 4.39E-01 4.38E-01 4.38E-01
10 3.99E-01 4.17E-01 3.95E-01 3.94E-01 3.94E-01
11 3.57E-01 3.72E-01 3.53E-01 3.52E-01 3.52E-01
12 3.27E-01 3.41E-01 3.23E-01 3.22E-01 3.23E-01
13 3.00E-01 3.12E-01 2.96E-01 2.95E-01 2.96E-01
14 2.76E-01 2.86E-01 2.72E-01 2.72E-01 2.72E-01
15 2.58E-01 2.68E-01 2.55E-01 2.55E-01 2.55E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 8.67E-01 8.76E-01 8.64E-01 8.62E-01 8.63E-01
4 8.00E-01 8.13E-01 7.96E-01 7.92E-01 7.94E-01
5 7.24E-01 7.42E-01 7.20E-01 7.15E-01 7.17E-01
6 6.45E-01 6.65E-01 6.40E-01 6.35E-01 6.38E-01
7 5.70E-01 5.89E-01 5.64E-01 5.60E-01 5.61E-01
8 5.01E-01 5.19E-01 4.96E-01 4.92E-01 4.94E-01
9 4.46E-01 4.61E-01 4.41E-01 4.39E-01 4.40E-01
10 4.01E-01 4.14E-01 3.97E-01 3.94E-01 3.96E-01
11 3.59E-01 3.70E-01 3.56E-01 3.53E-01 3.55E-01
12 3.28E-01 3.37E-01 3.26E-01 3.24E-01 3.26E-01
13 3.00E-01 3.09E-01 3.00E-01 2.98E-01 3.00E-01
14 2.77E-01 2.84E-01 2.76E-01 2.76E-01 2.77E-01
15 2.60E-01 2.66E-01 2.60E-01 2.60E-01 2.61E-01
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Table 3.7. Absorbed fractions to TAMs for the a-particle emission within TBV for all
bone sites and for 100% cellularities.
AF(TAMs*--TBV)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 1.73E-02 2.61E-02 2.44E-02 2.60E-02 3.23E-02
4 2.63E-02 3.95E-02 3.70E-02 3.93E-02 4.87E-02
5 3.61E-02 5.42E-02 5.08E-02 5.40E-02 6.69E-02
6 4.62E-02 6.95E-02 6.49E-02 6.90E-02 8.53E-02
7 5.61E-02 8.42E-02 7.81E-02 8.34E-02 1.03E-01
8 6.49E-02 9.76E-02 9.04E-02 9.62E-02 1.18E-01
9 7.21E-02 1.08E-01 9.94E-02 1.06E-01 1.30E-01
10 7.76E-02 1.15E-01 1.06E-01 1.14E-01 1.37E-01
11 8.30E-02 1.21E-01 1.12E-01 1.21E-01 1.44E-01
12 8.70E-02 1.25E-01 1.16E-01 1.25E-01 1.48E-01
13 9.07E-02 1.29E-01 1.20E-01 1.29E-01 1.50E-01
14 9.40E-02 1.31E-01 1.22E-01 1.32E-01 1.52E-01
15 9.65E-02 1.32E-01 1.23E-01 1.34E-01 1.52E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 2.33E-02 2.51E-02 3.36E-02 3.55E-02 3.52E-02
4 3.53E-02 3.77E-02 5.09E-02 5.34E-02 5.31E-02
5 4.85E-02 5.19E-02 7.00E-02 7.40E-02 7.30E-02
6 6.19E-02 6.62E-02 8.94E-02 9.43E-02 9.30E-02
7 7.46E-02 7.99E-02 1.08E-01 1.13E-01 1.12E-01
8 8.65E-02 9.24E-02 1.25E-01 1.31E-01 1.29E-01
9 9.50E-02 1.02E-01 1.37E-01 1.43E-01 1.42E-01
10 1.02E-01 1.09E-01 1.46E-01 1.52E-01 1.50E-01
11 1.07E-01 1.15E-01 1.54E-01 1.60E-01 1.56E-01
12 l.llE -01 1.19E-01 1.58E-01 1.64E-01 1.60E-01
13 1.14E-01 1.22E-01 1.62E-01 1.68E-01 1.62E-01
14 1.17E-01 1.24E-01 1.64E-01 1.70E-01 1.63E-01
15 1.18E-01 1.25E-01 1.65E-01 1.70E-01 1.62E-01
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Figure 3.4. Absorbed fraction within trabecular bone for different bone sites and sources 
in TAM, TAMs, and TBV.
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the maximum value of 0.11 at 15 MeV within the occipital bone. At energies below 
15 MeV, this source results in the smallest absorbed fractions to the TBV target due to 
the fact that the a-particle will not be energetic enough to reach the TBV; therefore, the 
AF(TBV<—TAM) values below 15 MeV have the smallest divergence from the initial AF 
value (at 3 MeV), among all the sources irradiating the TBV. Table 3.8 shows the 
AF(TBV<—TAM), for all bone sites.
Values of AF(TBV<—TAMs) at 3 MeV start at 0.04 in the ribs, 0.05 in the 
sacrum, and 0.06 in the cranium. Table 3.9 shows the AF(TBV<—TAMs), for all bone 
sites. Absorbed fractions approach the maximum values of AF(TBV<—TAMs) in the 
cranium (0.06 at 3 MeV and 0.37 at 15 MeV) and minimum values in the ribs (0.04 at 3 
MeV and 0.22 at 15 MeV), at all energies. The TAMs source contributes a higher value 
of AF to the TBV than the source located in the TAM, as expected. The probability of 
energy deposition inside the TBV is bigger for a-particles originating in the TAMs rather 
then the TAM, because the TAMs and TBV are adjacent regions.
Values of the AF(TBV<—TBV) at 3 MeV are 0.96, 0.97, and 0.98 in the sacrum, 
ribs, and the cranium, respectively. At 15 MeV those values are 0.63 in the sacrum, 0.72 
in the ribs, and 0.81 in the cranium. Table 3.10 shows the AF(TBV<—TBV) for all bone 
sites. Values of the AF(TBV<—TBV), at lower energies, start at -1 .0  (3 MeV) and 
decrease to 0.82 -  0.63 (15 MeV), for all the bone sites. Alpha-particles, due to their 
short ranges, deposit the highest amount o f energy during the self-irradiation. However, a 
very small portion o f the energy is deposited to the surrounding tissues from the a- 
particles originating near the TBV boundary. The ICRP 30 bone model does not consider 
TBV as a target region (trabecular bone surface (TBS) is considered instead). However,
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Table 3.8. Absorbed fractions to TBV for the a-particle emission within TAM for all
bone sites and for 100% cellularities.
A F(TBV ^ TAM)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 3.38E-04 8.29E-05 2.44E-04 2.34E-04 1.55E-04
4 8.14E-04 1.97E-04 5.72E-04 5.65E-04 3.77E-04
5 1.64E-03 3.94E-04 1.17E-03 1.13E-03 7.51E-04
6 2.92E-03 7.05E-04 2.07E-03 2.03E-03 1.34E-03
7 4.84E-03 1.18E-03 3.41E-03 3.41E-03 2.19E-03
8 8.11E-03 1.96E-03 5.72E-03 5.65E-03 3.71E-03
9 1.37E-02 3.31E-03 9.58E-03 9.42E-03 6.08E-03
10 2.13E-02 5.07E-03 1.47E-02 1.46E-02 9.28E-03
11 3.12E-02 7.38E-03 2.14E-02 2.12E-02 1.34E-02
12 4.17E-02 9.76E-03 2.85E-02 2.80E-02 1.78E-02
13 5.37E-02 1.25E-02 3.66E-02 3.60E-02 2.25E-02
14 6.74E-02 1.54E-02 4.55E-02 4.49E-02 2.78E-02
15 8.11E-02 1.84E-02 5.46E-02 5.37E-02 3.31E-02
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 1.66E-04 1.09E-04 2.07E-04 2.11E-04 1.47E-04
4 3.78E-04 2.60E-04 4.95E-04 4.96E-04 3.50E-04
5 7.68E-04 5.16E-04 l.OOE-03 9.88E-04 7.20E-04
6 1.35E-03 9.24E-04 1.78E-03 1.75E-03 1.28E-03
7 2.21E-03 1.54E-03 2.94E-03 2.90E-03 2.11E-03
8 3.75E-03 2.63E-03 4.95E-03 4.86E-03 3.50E-03
9 6.25E-03 4.52E-03 8.27E-03 7.94E-03 5.82E-03
10 9.54E-03 7.06E-03 1.27E-02 1.22E-02 8.66E-03
11 1.39E-02 1.04E-02 1.85E-02 1.76E-02 1.25E-02
12 1.85E-02 1.38E-02 2.44E-02 2.32E-02 1.64E-02
13 2.35E-02 1.78E-02 3.12E-02 2.97E-02 2.07E-02
14 2.92E-02 2.22E-02 3.87E-02 3.68E-02 2.53E-02
15 3.49E-02 2.65E-02 4.62E-02 4.37E-02 2.99E-02
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Table 3.9. Absorbed fractions to TBV for the a-particle emission within TAMs for all
bone sites and for 100% cellularities.
A F(T B V ^ TAMs)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 6.48E-02 4.21E-02 6.07E-02 6.22E-02 5.55E-02
4 9.82E-02 6.39E-02 9.20E-02 9.48E-02 8.42E-02
5 1.36E-01 8.83E-02 1.27E-01 1.30E-01 1.16E-01
6 1.75E-01 1.14E-01 1.63E-01 1.67E-01 1.49E-01
7 2.15E-01 1.39E-01 2.00E-01 2.04E-01 1.81E-01
8 2.51E-01 1.62E-01 2.31E-01 2.37E-01 2.09E-01
9 2.78E-01 1.79E-01 2.55E-01 2.62E-01 2.29E-01
10 3.00E-01 1.91E-01 2.73E-01 2.80E-01 2.43E-01
11 3.21E-01 2.02E-01 2.89E-01 2.97E-01 2.55E-01
12 3.37E-01 2.09E-01 3.00E-01 3.08E-01 2.62E-01
13 3.52E-01 2.14E-01 3.10E-01 3.18E-01 2.67E-01
14 3.65E-01 2.19E-01 3.19E-01 3.28E-01 2.70E-01
15 3.76E-01 2.21E-01 3.24E-01 3.32E-01 2.71E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 5.53E-02 4.59E-02 5.72E-02 5.85E-02 5.39E-02
4 8.37E-02 7.02E-02 8.69E-02 8.88E-02 8.11E-02
5 1.16E-01 9.64E-02 1.20E-01 1.22E-01 1.12E-01
6 1.49E-01 1.25E-01 1.54E-01 1.56E-01 1.44E-01
7 1.81E-01 1.53E-01 1.88E-01 1.91E-01 1.75E-01
8 2.11E-01 1.78E-01 2.18E-01 2.21E-01 2.02E-01
9 2.32E-01 1.97E-01 2.40E-01 2.42E-01 2.21E-01
10 2.48E-01 2.11E-01 2.56E-01 2.57E-01 2.34E-01
11 2.63E-01 2.23E-01 2.69E-01 2.70E-01 2.45E-01
12 2.73E-01 2.32E-01 2.78E-01 2.79E-01 2.50E-01
13 2.81E-01 2.39E-01 2.85E-01 2.85E-01 2.53E-01
14 2.88E-01 2.45E-01 2.90E-01 2.90E-01 2.56E-01
15 2.92E-01 2.48E-01 2.92E-01 2.90E-01 2.56E-01
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Table 3.10. Absorbed fraction values for self-irradiation o f trabecular bone volume
A F(TB V ^ TBV)
Energy (MeV) Cranium Ribs Femur Humerus Pelvis
3 9.82E-01 9.73E-01 9.75E-01 9.73E-01 9.67E-01
4 9.73E-01 9.59E-01 9.62E-01 9.59E-01 9.49E-01
5 9.62E-01 9.43E-01 9.46E-01 9.43E-01 9.29E-01
6 9.50E-01 9.25E-01 9.30E-01 9.25E-01 9.07E-01
7 9.38E-01 9.05E-01 9.12E-01 9.07E-01 8.84E-01
8 9.25E-01 8.85E-01 8.94E-01 8.88E-01 8.60E-01
9 9.12E-01 8.65E-01 8.76E-01 8.68E-01 8.35E-01
10 8.99E-01 8.44E-01 8.57E-01 8.47E-01 8.10E-01
11 8.83E-01 8.20E-01 8.35E-01 8.24E-01 7.82E-01
12 8.68E-01 7.97E-01 8.15E-01 8.02E-01 7.55E-01
13 8.52E-01 7.73E-01 7.92E-01 7.78E-01 7.27E-01
14 8.35E-01 7.48E-01 7.68E-01 7.52E-01 6.96E-01
15 8.19E-01 7.24E-01 7.46E-01 7.28E-01 6.67E-01
Energy (MeV) Scapula Clavicle Vertebrae Sacrum Sternum
3 9.76E-01 9.74E-01 9.66E-01 9.64E-01 9.64E-01
4 9.63E-01 9.61E-01 9.47E-01 9.44E-01 9.45E-01
5 9.49E-01 9.45E-01 9.26E-01 9.21E-01 9.22E-01
6 9.33E-01 9.28E-01 9.03E-01 8.97E-01 8.98E-01
7 9.16E-01 9.10E-01 8.78E-01 8.72E-01 8.72E-01
8 8.98E-01 8.91E-01 8.53E-01 8.46E-01 8.46E-01
9 8.81E-01 8.72E-01 8.28E-01 8.19E-01 8.19E-01
10 8.62E-01 8.52E-01 8.01E-01 7.92E-01 7.92E-01
11 8.42E-01 8.30E-01 7.71E-01 7.60E-01 7.62E-01
12 8.23E-01 8.08E-01 7.43E-01 7.32E-01 7.33E-01
13 8.01E-01 7.86E-01 7.13E-01 7.00E-01 7.03E-01
14 7.78E-01 7.62E-01 6.81E-01 6.67E-01 6.72E-01
15 7.56E-01 7.39E-01 6.52E-01 6.36E-01 6.43E-01
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absorbed fractions to this target region show high energy dependence and should be 
considered in future dosimetric models. The absorbed fraction values to TAM for all 
sources and all 33 pCT bone sites are shown in Appendix C (tables) and Appendix D 
(graphs).
Influence o f Marrow Cellularity on a-Particle Absorbed Fractions
Figure 3.5 shows the absorbed fractions to TAM for a-particles starting in the 
TAM, TAMs, and TBV within the vertebrae (values o f AF from all vertebrae are volume 
averaged), with cellularities ranging from 20% to 100%. Adipocytes are placed only in 
the marrow cavities and, thus, cellularity has no effect on the values of the absorbed 
fraction in the TBV region.
For the self-irradiation of deep marrow, the ICRP Publication 30 model is shown 
to closely approximate values of AF(TAM<—TAM) = 1.0 given by the 3D voxelized 
image based transport model only for 100% marrow cellularity (1.0 at 3 meV and 0.83 -  
0.95 at 15 MeV, for all bone sites). As adipocyte concentrations increase (marrow 
cellularities decrease), less a-particle energy is deposited within active marrow, and a 
greater divergence of AF(TAM<—TAM) from the unity assumption is noted at all 
energies. Furthermore, at a-energies below 15 MeV, values o f AF(TAM*—TAM) at 
different marrow cellularities are shown not to scale as simple ratios o f their 
corresponding cellularities; At 3 MeV these values are 0.83, 0.87, 0.91, 0.95, and 1.00 for 
the 20, 40, 60, 80, and 100 pereent cellularities, respectively; consequently, full 3D 
transport is thus required to accurately report values o f a-particle absorbed fraction.
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Figure 3.5. Deep marrow absorbed fractions averaged for the vertebrae as a function of 
marrow cellularity for sources in a) TAM, b) TAMs, and c) TBV.
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Effects o f increased adipocyte concentration are demonstrated for a-sources 
within the shallow marrow in Fig 3.5b. As marrow cellularity decreases, a-particles 
emerging from the shallow marrow layer increasingly encounter adipocytes, thus, values 
o f AF(TAM<—TAMs) decline in value at all energies. For 15 MeV a-particles, 
AF(TAM<—TAMs) values are 0.09, 0.18, 0.27, 0.36, and 0.45 for the 20, 40, 60, 80, and 
100 percent cellularities, respectively. This source region is not discussed in the ICRP 30 
bone model. Flowever, the energy and cellularity dependence of the AF(TAM<—TAMs) 
shown in this study suggests that this source region should be considered in future 
dosimetric models.
The influence of marrow cellularity on values of AF(TAM<—TBV) is 
demonstrated in Fig. 3.5c. The ICRP Publication 30 bone model suggests the value of 
0.05 for the AF(TAM-<—TBV), which is not reached until the a-emission energies 
approach 9 MeV, for 100% cellularity. The AF(TAM<—TBV) never reaches 0.05 for 20% 
cellularities, at all energies. Above 9 MeV, the ICRP Publication 30 bone model 
underestimates absorbed fraction values to this source-target combination. At 15 MeV, 
values o f AF(TAM<—TBV) range from 0.18 to 0.04, depending on the cellularity.
Additionally, effects of cellularity on absorbed fraction within the shallow 
marrow were investigated. Differences in absorbed fraction values for different 
cellularities tend to be small at low energies due to the number and location of trabeculae 
in the bone microstructure. Figure 3.6 shows the absorbed fractions to TAMs for a- 
particles starting in the TAM, TAMs, and TBV within the frontal bone with cellularities 
ranging from 20% to 100%.
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Figure 3.6. Shallow marrow absorbed fractions for the frontal bone as a function of 
marrow cellularity for sources in a) TAM, b) TAMs, and c) TBV.
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AF(TAMs<—TAM) values for all cellularities start at 0.01 -  0.02 (3 MeV) and 
approach values o f 0.02, 0.04, 0.06, 0.08, and 0.1 for the 20, 40, 60, 80, and 100 percent 
cellularities at 15 MeV. At 15 MeV, the maximum difference between absorbed fraction 
values of 20% and 100% cellularity is ~8% (0.02 and 0.1, respectively).
Figure 3.6b shows absorbed fraction to TAMs for a-sources localized within the 
shallow marrow. At low energies (3 MeV) the values of AF(TAMs<—TAMs) are between 
0.86 and 0.79, for all cellularities. The values of AF(TAMs<—TAMs), at 15 MeV, are 
between 0.26 and 0.09, for all cellularities.
Figure 3.6c shows the effect of the cellularity on AF(TAMs<—TBV) values which 
show the same behavior as AF(TAMs<—TAM). In this case, absorbed fraction values start 
at zero (3 MeV) for all cellularities and increase to 0.1 at 15 MeV for 100% cellularity, 
but only to 0.02 for the 20% cellularity. The ICRP 30 bone model does not consider the 
TAMs target region. Our study showed the energy-dependence of the absorbed fractions 
to TAMs. Additionally, effects of marrow cellularity to TAMs region were ivestigated.
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CHAPTER 4 
CONCLUSION
In this study a 3D voxelized image based transport model was developed that 
transports a-particles through pCT images of trabecular bone. Absorbed fractions were 
calculated for three target-source regions (TAM, TAMs, and TBV) and for a broad range 
of a-particle kinetic energy. Thirty three images were examined and absorbed fraction 
values were tabulated for energies up to 15 MeV. Using bone site volume fractions of 
similar anatomical features, absorbed fractions were combined and averaged into skeletal 
site specific AF values. Absorbed fractions to the deep marrow region were calculated for 
various marrow cellularities, with results, suggesting that cellularity must be considered 
in any model used in bone dosimetry. Values o f AF(TAM<—TAM), at 100% cellularity, 
were a factor of 3 greater than values of 20% cellularity, at 3 MeV, and a factor of 5 
greater at 15 MeV. Cellularity effects on TAMs were also considered. Results for shallow 
marrow self-irradiation show that absorbed fractions for 100% cellularity were a factor of 
3 greater than values of 20% cellularity, at 3 MeV, and a factor o f 4 greater at 15 MeV. 
The adipose tissue was placed only in the marrow cavities; therefore, cellularity had no 
effect on the values of the absorbed fraction in the TBV region.
Absorbed fractions for target being equal to the source follow the expected 
patterns at 100% cellularity. For all 3 targets, the absorbed fractions start at -1 .0  at low 
energy and decrease as the kinetic energy of the a-particles increase. The values decrease
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by -10%  to -60%  at higher energy when compared to the low energy values (-1.0). This 
shows that there is an energy dependence for absorbed fractions even for a-particles in 
the trabecular bone regions, and thus, highlights flaws in the current methods used for 
bone dosimetry.
Values o f AF(TAM<—TAMs) start at -0.1 at low energy and increase with the 
kinetic energy of the a-particles. The values increase to -0.5 at higher energy when 
compared to the low energy values (-0.1). ICRP publications (ICRP 30 and ICRP 60) do 
not consider the shallow marrow region as a target but consider only a 10 pm endosteal 
layer. However, previous studies show that radiosensitive progenitor cells are located as 
deep as 50 pm from the trabecular bone surface (Yin and Li, 2006; Haylock and Nilsson, 
2006); therefore, we considered shallow marrow layer as a source and target region in our 
calculations.
ICRP Publication 30 model applies an energy-independent value of 0.05 to 
AF(TAM<—TBV). Our study shows that for this source-target combination, absorbed 
fractions start at zero, at low energy, and increase to 0.2 at higher energy. This study 
shows values o f AF(TAM<—TBV) less then 0.05 at a-energies below -  9 MeV for all 
bone sites, with higher absorbed fractions to bone marrow seen at energies exceeding 
11 MeV.
Values o f both, AF(TAMs<—TAM) and AF(TAMs<—TBV), start at zero, at low 
energy. As the kinetic energy of the a-particles increase, values o f AF increase to 0.1 and 
0.17, for the TAM and TBV sources, respectively.
ICRP Publication 30 suggests energy and cellularity independent values of 
absorbed fractions for a-particles. ICRP 30 value of absorbed fraction for self-irradiation
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of the target is 1.0. Our study shows that these values diverge from the initial unity 
assumption when energy increases. These values are also influenced by the marrow 
cellularity.
The energy independent value of 0.05 is adapted by the ICRP 30, for irradiation 
o f the TAM target by the TBV. Our study shows that absorbed fractions for this source- 
target combination are lewer or higher then 0.05, depending on the energy and the 
marrow cellularity.
ICRP 30 does not consider the TAMs as the source or target region. Our study 
shows that absorbed fractions to this target are energy dependent, as well as, they change 
with the marrow cellularity. The TAMs source also contributes high values of absorbed 
fractions to all target regions.
Our study suggests that, in the future methods for bone dosimetry, absorbed 
fraction dependence on energy, as well as, marrow cellularity must be considered. The 
absorbed fractions to the shallow marrow region must be further investigated. The study 
encourages the future use of chord length distribution based models to calculate a- 
particle absorbed fractions, for various marrow cellularities and 33 pCT images, used in 
this study. This would illustrate the need for a new approach to the a-particle absorbed 
fraction values in future bone dosimetry models.
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